{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001935979","name":"Biohaven Ltd.","summary":"Biohaven Ltd. is a biopharmaceutical company focused on discovery, development, and commercialization of treatments in immunology, neuroscience, and oncology. Key programs include BHV-1300, a MoDE degrader targeting IgG for Graves' Disease and Rheumatoid Arthritis; BHV-1400, a TRAP degrader targeting Gd-IgA1 for IgA Nephropathy; Kv7 ion channel modulation for epilepsy; and myostatin-activin pathway targeting for neuromuscular and metabolic diseases including obesity. The company became independent via spin-off from Biohaven Pharmaceutical Holding Company in October 2022.","people":[],"products":[{"name":"BHV-1300","type":"platform","description":"MoDE bispecific degrader targeting IgG1/2/4 for Graves' Disease and Rheumatoid Arthritis, administered subcutaneously via autoinjector, in Phase 1 clinical trials."},{"name":"BHV-1400","type":"platform","description":"TRAP degrader selectively targeting pathogenic Gd-IgA1 for IgA Nephropathy without suppressing healthy immunoglobulins, in Phase 1 clinical trials."},{"name":"Kv7 ion channel modulator","type":"platform","description":"Late-stage clinical program targeting Kv7 ion channels for the treatment of epilepsy."},{"name":"Myostatin-activin pathway targeting agent","type":"platform","description":"Clinical program targeting myostatin-activin pathway for neuromuscular and metabolic diseases including obesity."}],"partnerships":[{"partner_name":"Ypsomed","partnership_type":"development","description":"Agreement to develop and manufacture BHV-1300 in an easy-to-use autoinjector for self-administration intended for commercialization.","start_date":null}],"affiliations":[],"origin":{"leaf":"7fda5165beac952dca0144e1f2f05f5357754530ca8f4f129fedfcf5af8470e0","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"473c90f960f13351ded74b4c102a287d70b1fb51b0079122ac5ad897071720e4","parent":"0d805d725cf260a909e1c2fd63f2f85e5225c6cf9cd8b1a273ab0238c18908e0","source":"0001935979-26-000020","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}